Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 27 May

Sophia Mavridis
May 27, 2022

Morning Bell 26 May

Paulina Peters
May 26, 2022

Morning Bell 25 May

Paulina Peters
May 25, 2022

Morning Bell 24 May

Sophia Mavridis
May 24, 2022

Morning Bell 23 May

Sophia Mavridis
May 23, 2022

Weekly Wrap 20 May

Sophia Mavridis
May 20, 2022

Morning Bell 19 May

Paulina Peters
May 19, 2022

Morning Bell 18 May

Sophia Mavridis
May 18, 2022

Morning Bell 17 May

Sophia Mavridis
May 17, 2022

Morning Bell 16 May

Paulina Peters
May 16, 2022

Weekly Wrap 13 May

Sophia Mavridis
May 13, 2022